Randomized Controlled and Prospective Trial of a Cohort of People Who Made a Suicide Attempt (OSTA)

April 10, 2013 updated by: Assistance Publique - Hôpitaux de Paris

Effectiveness of Telephone Contact and Professional Coordination for Preventing Recurrent Suicidal Acts

The prevention of recurrent suicidal about people who have made a suicide attempt is a major strand in the prevention of suicide. It is estimated that 10-15 % of people who made a suicide attempt die by suicide. Recidivism rate of suicide increases even faster than the subject is close to the index suicide attempt. A one month recurrence rate is 5 %, 12-25 % at one year. Most people who made a suicide attempt receive ambulatory monitoring. On this population, there is a low adherence to care.

The main objective of the study is to test the effectiveness of a prevention program of recurrent suicidal acts for people who made a suicide attempt.

The secondary objectives of this study are the assessment of adherence to care; the identification of sub - populations benefiting most from this program; the evaluation of the possible generalization level of the program (eligibles persons rate) and its feasibility level.

Study Overview

Detailed Description

This is a randomized, controlled and prospective trial comparing an experimental group (usual treatment + interventions) to a control group (usual treatment only). All participants are evaluated after one year of monitoring. The search duration is 2 years (one inclusion year and one year of follow-up). It is planned to include 330 patients, 165 patients in each group.

The program (experimental group) includes three interventions:

  • A series of three telephone calls ( the second week , one month and three months after discharge from hospital )
  • A systematic telephone contact with the referring physician
  • A telephone helpline for people who made a suicide attempt and referring physicians.

Study Type

Interventional

Enrollment (Actual)

320

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Le Kremlin Bicetre, France, 94275
        • Assistance Publique - Hôpitaux de Paris : BICETRE Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adults ≥ 18 years.
  • Patients admitted to the emergency department for a suicide attempt.
  • Patients referred to outpatient care.
  • Patients who have given their written consent.

Exclusion Criteria:

  • Patients not affiliated to social security.
  • Patients do not have the faculties needed to be evaluated (cognitive or delusional disorder).
  • Patients hospitalized for longer than 72 hours.
  • Patients can not be recalled by phone (no phone, homeless, incarcerated)
  • Patients who do not speak French.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Interventional group
Usual treatment + prevention program of recurrent suicidal acts

Prevention program of recurrent suicidal acts includes three interventions:

  • A series of three telephone calls ( the second week , one month and three months after discharge from hospital )
  • A systematic telephone contact with the referring physician
  • A telephone helpline for people who made a suicide attempt and referring physicians.
Other Names:
  • Prevention program
Active Comparator: Control group
Usual treatment
Usual Treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
suicidal act frequency
Time Frame: 12 months
The primary endpoint is the occurrence of a suicidal act (occurrence or not). The suicidal act includes suicide and suicide attempt.
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
suicide attempts frequency
Time Frame: 12 months
Number of occurrence of suicide attempts.
12 months
Adherence to health care
Time Frame: 12 months

Adherence to health care:

Defined by:

  • The Initialization of outpatient care proposed by the suicidology's team at the initial interview or during telephone contacts.
  • The number of consultations within 3 months after the first appointment with the referring doctor.
12 months
Number of eligibles persons
Time Frame: 12 months

Number of eligibles persons:

Number of people (among all people admitted to the emergency department fo a suicide attempt) meeting the criteria of selection.

12 months
Number of participants responding to telephone calls
Time Frame: 12 months

Number of participants responding to telephone calls:

We consider the failure to call after three unsuccessful telephone calls to three different days.

12 months
Number of people lost sight of
Time Frame: 12 months

Number of people lost sight of:

A person is considered lost sight if no information can be obtained after contact with the person himself, a third (nearest designated), a doctor (general practitioner and / or psychiatrist) and the nearest emergency department.

12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Arnaud MARCHAND, MD, Assistance Publique - Hôpitaux de Paris

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2009

Primary Completion (Actual)

November 1, 2012

Study Completion (Actual)

November 1, 2012

Study Registration Dates

First Submitted

August 5, 2010

First Submitted That Met QC Criteria

August 5, 2010

First Posted (Estimate)

August 6, 2010

Study Record Updates

Last Update Posted (Estimate)

April 11, 2013

Last Update Submitted That Met QC Criteria

April 10, 2013

Last Verified

April 1, 2013

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Suicide, Attempted

Clinical Trials on Usual treatment and Prevention program

3
Subscribe